(Q38113160)

29 August 2017

title

Impact of antiplatelet therapy on clinical manifestations and outcomes of cardiovascular infections (English)

1 reference

29 August 2017

Ammar Habib

1

1 reference

29 August 2017

Larry M Baddour

series ordinal

2

1 reference

29 August 2017

M Rizwan Sohail

series ordinal

3

1 reference

29 August 2017

publication date

1 August 2013

1 reference

Current infectious disease reports

29 August 2017

published in

1 reference

29 August 2017

volume

15

1 reference

29 August 2017

issue

4

1 reference

29 August 2017

page(s)

347-352

1 reference

Mortality and cost associated with cardiovascular implantable electronic device infections

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0347-Z

Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0347-Z

Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0347-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0347-Z

Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0347-Z

Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0347-Z

Eradication of biofilm-forming Staphylococcus epidermidis (RP62A) by a combination of sodium salicylate and vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0347-Z

Aspirin to prevent growth of vegetations and cerebral emboli in infective endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0347-Z

A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0347-Z

Effect of long-term aspirin use on embolic events in infective endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0347-Z

Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0347-Z

Statins for the prevention and treatment of infections: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0347-Z

Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0347-Z

Chronic antiplatelet therapy and mortality among patients with infective endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0347-Z

Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0347-Z

Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0347-Z

21 January 2018

Coagulation in sepsis

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0347-Z

Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections

21 January 2018

1 reference

12 December 2020

Influence of adjunctive ticlopidine on the treatment of experimental Staphylococcus aureus endocarditis

1 reference

12 December 2020

Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus

1 reference

12 December 2020

Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects

1 reference

12 December 2020

Risk of embolization after institution of antibiotic therapy for infective endocarditis

1 reference

12 December 2020

The relationship between cerebrovascular complications and previously established use of antiplatelet therapy in left-sided infective endocarditis

1 reference

12 December 2020

Reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate

1 reference

12 December 2020

Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis.

1 reference

12 December 2020

Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis

1 reference

12 December 2020

Impact of early surgery on embolic events in patients with infective endocarditis

1 reference

12 December 2020

Platelet interaction with bacteria. IV. Stimulation of the release reaction

1 reference

12 December 2020

Mechanisms of intracranial hemorrhage in infective endocarditis

1 reference

12 December 2020

Effect of statins on platelet PAR-1 thrombin receptor in patients with the metabolic syndrome (from the PAR-1 inhibition by statins [PARIS] study)

1 reference

12 December 2020

Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections

1 reference

12 December 2020

10.1007/S11908-013-0347-Z

Identifiers

DOI

1 reference

29 August 2017

1 reference